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Abstract  
Introduction: The most commonly used threshold of expired-air carbon monoxide (CO) concentration to 
validate self-reported smoking abstinence is <10 parts per million (ppm). It has been proposed to reduce 
this threshold. This study examined what effect a reduction would have on short-term success rates in 
clinical practice.  
Methods: A total of 315,718 quit attempts supported by English NHS Stop Smoking Services were included 
in the analysis. The proportion of 4-week quits as determined by the Russell standard (<10ppm) that also 
met lower thresholds was calculated for each unit change from <9ppm to <2ppm. Additionally, associations 
of established predictors with outcome were assessed in logistic regressions for selected thresholds.  
Results: At <10ppm, 35% of quit attempts were regarded as successful. Differences for a single unit 
reduction increased with each reduction; small reductions had very little impact (e.g. <8ppm: 34.7% 
success), but at <3ppm, only 26.3% would still be regarded as successful. With the threshold reduced to 
<3ppm established predictors of cessation showed a weaker association with outcome than with the 
threshold at <10ppm suggesting an increase in error of outcome measurement.  
Conclusions: Reducing the threshold for expired-air CO concentration to validate abstinence would have a 
minimal effect on success rates unless the threshold were reduced substantially which would likely increase 
error of measurement.  
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1. Introduction 
Measurement of biochemical markers of smoking (e.g. cotinine, carbon monoxide) can provide more 
accurate information on smoking status than self-report (Jarvis, Tunstall-Pedoe, Feyerabend, Vesey, & 
Saloojee, 1987; SRNT Subcommittee on Biochemical Verification, 2002) and is recommended as standard in 
clinical trials and routine clinical practice (Department of Health, 2011; SRNT Subcommittee on Biochemical 
Verification, 2002; West, Hajek, Stead, & Stapleton, 2005). Biochemical markers are widely used in research 
and clinical practice (e.g. Department of Health, 2011; Fidler, et al., 2011; Stapleton & Sutherland, 2011).  
Although the nicotine metabolite cotinine is an optimal biomarker for discriminating smokers from non-
smokers (Jarvis, et al., 1987) expired-air carbon-monoxide (CO) also has good sensitivity (percent of non-
smokers classified correctly) and specificity (percent of smokers classified correctly) (SRNT Subcommittee 
on Biochemical Verification, 2002). As it is cheaper and easier to use, provides immediate results and, 
unlike cotinine, can be used with people who are obtaining nicotine from nicotine replacement therapy, it 
is recommended for use in routine clinical practice (Department of Health, 2011; West, et al., 2005). 
The most commonly used CO threshold for validating smokers’ self-reported abstinence is 10 parts per 
million (ppm), as for example defined by the Russell Standard (Clinical) (Department of Health, 2011; West, 
et al., 2005).  
It has been argued that the threshold should be reduced to increase specificity, and a number of lower 
thresholds have been proposed, ranging from 6.5ppm (Deveci, Deveci, Acik, & Ozan, 2004) through 5 ppm 
(Low, Ong, & Tan, 2004; Maclaren, et al., 2010; Middleton & Morice, 2000; Secker-Walker, Vacek, Flynn, & 
Mead, 1997) to 2-3ppm (Cropsey, Eldridge, Weaver, Villalobos, & Stitzer, 2006; Javors, Hatch, & Lamb, 
2005). However, little information is available on the effect of different thresholds in practice.  
The UK has the most extensive coverage of smoking cessation support clinics of any country and 
information is recorded on the clients attending the services, the support they receive and success rates as 
defined according to the Russell Standard (Department of Health, 2011). The available information provides 
a unique opportunity to assess the effect lower thresholds would have on success rates reported in clinical 
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practice. Because no other objective measure of abstinence such as cotinine is being recorded in the 
services, it is not possible to calculate sensitivity and specificity, thus the aim of this study was to assess the 
impact of reducing the threshold for expired-air CO below 10ppm on success rates in clinical practice.  
2. Material and methods 
2.1. Design 
Data were obtained from QuitManager (North 51, Nottingham, UK), an online database system for 
recording information on client and intervention characteristics in accordance with the Department of 
Health’s standard monitoring requirements (Department of Health, 2011). In 2011, there were about 150 
stop smoking services across England, of which 58 Services used QuitManager and 47 agreed to share 
anonymised data for the current audit. 
2.2. Participants 
As defined by the Department of Health, a treatment episode is completed with a follow-up four weeks 
after the quit date. Out of all 315,718 completed treatment episodes between April 2009 and June 2011, 
we identified 111,046 completed treatment episodes in which the client reported abstinence and expired-
air CO was assessed.  
2.3. Measures 
The main outcome measure was CO-validated 4-week quit rates as defined by the Department of Health in 
England (2011), i.e. the client reports abstinence from smoking between weeks 2 and 4 and records an 
expired-air CO concentration below a pre-defined threshold, currently 10ppm. CO concentration in expired 
air was measured using CO monitors, which are required to be calibrated and checked regularly across the 
Services. For those not reporting abstinence, CO concentration were only recorded for a very small 
minority (4.9%), so they were not included in any analysis.   
Information on some known predictors of quit success (Bauld, Bell, McCullough, Richardson, & Greaves, 
2010; Brose, et al., 2011) were recorded; this included participants’ age, gender, exemption from 
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prescription charges (exemption, pays for prescription, unknown), and medication used during the quit 
attempt (none, single form of nicotine replacement therapy or combination of two or more forms of 
nicotine replacement therapy, bupropion, varenicline). 
2.4. Analysis 
The proportions of those who, at 4-week follow-up, reported not having smoked for at least two weeks and 
had an expired-air CO concentration of less than 10ppm who would also have met stricter criteria were 
calculated for each unit decrease from <9ppm to <2ppm. 
Additionally, the association of known predictors of successful quit attempts and quit rates was calculated 
using logistic regression for selected thresholds (<10ppm and <3ppm). A reduction in association was 
interpreted as an indication of decreased accuracy.  
3. Results 
Out of all 315,718 completed treatment episodes, 110,558 (35.0%) reported abstinence and had a CO value 
of less than 10ppm. The size of the difference for a single unit reduction increased with each reduction; 
initial single unit reductions made a very small difference, while the two lowest thresholds reduced the 
proportion of quit attempts defined as successful by about a quarter and by about a half, respectively 
(Table 1).  
Logistic regressions showed weaker associations for all established predictors when the outcome was 
defined using the threshold of less than 3ppm (Table 2). This was indicated by smaller odds ratios and 
confidence intervals that did not include the odds ratio obtained from the model using the 10ppm 
threshold for all predictors with the exception of the ‘unknown’ group for prescription charge exemption. A 
smaller Nagelkerke’s R2 (0.04 versus 0.06) also indicated reduced fit for the model using the 3ppm 
threshold.   
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4. Discussion 
We found evidence that a reduction of the threshold for expired-air CO concentration to validate 
abstinence would reduce success rates in clinical practice only marginally unless very low thresholds were 
introduced. An extreme reduction also weakened the association of quit success with previously 
established predictors, suggesting that more error would be introduced and accuracy reduced if such a 
threshold were used. Low thresholds may however be useful in specific situations in which the aim is to 
maximize identification of those exposed to tobacco smoke or other sources of CO.  
The main strength of this study is that it was based on a large sample of smokers who sought help to stop 
smoking. The clients and intervention of the included services have been shown to be representative for 
those across England (Brose, et al., 2011). The main limitation of the study is the lack of information on CO 
measurements in those not reporting abstinence and the lack of other biochemical measures of smoking 
status, which made it not possible to calculate sensitivity and specificity for the various thresholds. 
However, the present data clearly show the impact (or lack thereof) that any changes would have on 
clinical practice.  
4.1. Conclusion 
A reduction of CO thresholds used to determine abstinence from smoking would have a very small effect 
on the success rates of attempts to stop smoking in clinical practice, unless thresholds were reduced 
drastically, which likely would decrease accuracy. 
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Table 1: Validated short-term success rates using different expired-air CO thresholds.  
Expired-air CO threshold 
Less than:  
CO-validated short term success 
rates, % of total N=315,718 
Classified as non-smoker, N (%) 
10ppm (Current standard) 35.0 110,558 (100) 
9ppm 34.9 110,128 (99.6) 
8ppm 34.7 109,508 (99.1) 
7ppm 34.4 108,537 (98.2) 
6ppm 33.6 106,211 (96.1) 
5ppm 32.6 102,976 (93.1) 
4ppm 30.7 96,839 (87.6) 
3ppm 26.3 83,186 (75.2) 
2ppm 18.9 59,737 (54.0) 
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Table 2: Logistic regression models predicting short-term abstinence using <10ppm and <3ppm expired-air 
CO thresholds, N=315,331. 
 Odds ratio (95% Confidence Interval), p-value 
 Validated by CO <10ppm  Validated by CO <3ppm  
Age (per 10 year increase) 1.20 (1.19 to 1.20), <0.001 1.16 (1.16 to 1.17), <0.001 
Gender (referent: Female) 1.04 (1.03 to 1.06) <0.001 0.93 (0.92 to 0.95), <0.001 
Medication (referent: None)   
 Single NRT 1.42 (1.38 to 1.46), <0.001 1.39 (1.34 to 1.43); <0.001 
 Bupropion 1.80 (1.67 to 1.95), <0.001 1.64 (1.51 to 1.79); <0.001 
Combination NRT 2.25 (2.19 to 2.32), <0.001 1.84 (1.78 to 1.90); <0.001 
 Varenicline 2.72 (2.64 to 2.80), <0.001 2.22 (2.15 to 2.29); <0.001 
Prescription charges 
(Referent: exempt) 
  
Pays 1.30 (1.27 to 1.32), <0.001 1.25 (1.23 to 1.28), <0.001 
Unknown 0.86 (0.84 to 0.88), <0.001 0.89 (0.87 to 0.92), <0.001 
*Missing data: N=344 
 
 
 
